Akzo Nobel To Pay $36M In Third Settlement Over Remeron Patent Evergreening
Dutch drug maker Akzo Nobel has agreed to pay $36 million to settle a class-action lawsuit brought by U.S. states and public sector health purchasers over an alleged attempt to evergreen...To view the full article, register now.
Already a subscriber? Click here to view full article